Methods for Monoclonal Antibody Generation
US-2024228595-A1 · Jul 11, 2024 · US
US2022177966A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022177966-A1 |
| Application number | US-202217592525-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 4, 2022 |
| Priority date | Feb 22, 2017 |
| Publication date | Jun 9, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An object of the present invention is to provide a means for detecting or quantitatively determining short-chain nucleic acids by simple double-strand formation with high specificity.The present invention relates to a polynucleobase probe including, in a sequence complementary to a target sequence having at least one sequence of any one of SEQ ID NOs: 1 to 10, a sequence in which at least one of bases in a portion complementary to any one sequence of SEQ ID NOs: 1 to 10 in the target sequence becomes abasic and/or is substituted; a method for designing the same; and a method for utilizing the same.
Opening claim text (preview).
1 . A method for detecting or quantitatively determining a target nucleic acid having at least one sequence of any one of SEQ ID NOs: 1 to 10 in a test sample with high specificity, the method comprising: preparing the test sample to detect the target nucleic acid; bringing at least one kind of polynucleobase probe in contact with the test sample, the polynucleobase probe comprising: in a sequence complementary to a target sequence having at least one sequence of any one of SEQ ID NOs: 1 to 10, a sequence in which at least one of bases in a portion complementary to any one sequence of SEQ ID NOs: 1 to 10 in the target sequence becomes abasic and/or is substituted; and/or a sequence which is cleaved to have, on an end, at least one sequence complementary to a sequence of 2 bases or less in anyone sequence of SEQ ID NOs: 1 to 10 in the target sequence; and detecting or quantitatively determining the target nucleic acid bound to the polynucleobase probe. 2 . The method according to claim 1 , wherein the polynucleobase probe is 15- to 28-mer. 3 . The method according to claim 1 , wherein a label is bound to the polynucleobase probe. 4 . The method according to claim 1 , wherein in the polynucleobase probe, in the portion complementary to any one sequence of SEQ ID NOs: 1 to 10 in the target sequence, at least one of the bases which become abasic or are substituted is located inside the portion complementary to any one sequence of SEQ ID NOs: 1 to 10 in the target sequence. 5 . The method according to claim 1 , wherein in the polynucleobase probe, in the sequence complementary to any one sequence of SEQ ID NOs: I to 10 in the target sequence, a ratio of at least one of the bases which become abasic or are substituted with respect to any one of 3 to 5 guanines and cytosines is 1. 6 . The method according to claim 1 , wherein the target nucleic acid is a miRNA. 7 . The method according to claim 1 , which the polynucleobase probe is a DNA, RNA, LNA, GNA, BNA, or PNA.
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title
DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title
miRNA, siRNA or ncRNA · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.